Tapewire

Nasdaq · USD

DNLI

Denali Therapeutics Inc.

Export transactions ↓
Tapewire entity
1735
SEC CIK
0001714899
Parsed reports
436

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 03, 2024 Filed Sep 4, 2024 22:26 UTC
SATO VICKI LDirector
SaleCommon Stock 100 $25.37 $2,537.00
Disclosure

SEC source: 0001714899-24-000198 · wk-form4_1725483889.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,176

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.

F3 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
September 03, 2024 Filed Sep 4, 2024 22:26 UTC
SATO VICKI LDirector
SaleCommon Stock 2,980 $24.99 $74,470.20
Disclosure

SEC source: 0001714899-24-000198 · wk-form4_1725483889.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,276

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.37 to $25.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
August 21, 2024 Filed Aug 22, 2024 20:14 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,547 $24.78 $63,114.66
Disclosure

SEC source: 0001714899-24-000195 · wk-form4_1724357674.xml · nonDerivative · entry 3

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,066

F3 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.

F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.19 to $25.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
August 21, 2024 Filed Aug 22, 2024 20:14 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 5,907 $24.96 $147,438.72
Disclosure

SEC source: 0001714899-24-000194 · wk-form4_1724357642.xml · nonDerivative · entry 3

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,810

F4 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29,2023.

F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.84 to $25.21 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
August 21, 2024 Filed Aug 22, 2024 20:14 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 14,098 $24.41 $344,132.18
Disclosure

SEC source: 0001714899-24-000194 · wk-form4_1724357642.xml · nonDerivative · entry 2

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,717

F4 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29,2023.

F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.84 to $24.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 20:16 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 2,260 $23.79 $53,765.40
Disclosure

SEC source: 0001714899-24-000197 · wk-form4_1724357777.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,807

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · balance_after: Includes 197,200 Unvested RSUs.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 20:14 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 3,353 $23.54 $78,929.62
Disclosure

SEC source: 0001714899-24-000195 · wk-form4_1724357674.xml · nonDerivative · entry 2

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 180,613

F3 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.38 to $23.72 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 20:14 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,453 $23.79 $58,356.87
Disclosure

SEC source: 0001714899-24-000195 · wk-form4_1724357674.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 183,966

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 20:15 UTC SaleCommon Stock 1,727 $23.79 $41,085.33
Disclosure

SEC source: 0001714899-24-000196 · wk-form4_1724357741.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,677

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.75 to $23.79 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 13,467 Unvested RSUs.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 20:14 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,453 $23.79 $58,356.87
Disclosure

SEC source: 0001714899-24-000194 · wk-form4_1724357642.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,815

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.62 to $23.79 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
August 13, 2024 Filed Aug 15, 2024 20:10 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,272 $22.89 $52,006.08
Disclosure

SEC source: 0001714899-24-000177 · wk-form4_1723752595.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,419

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · balance_after: Includes 123,810 RSUs.

F3 · balance_after: Includes 1,350 shares acquired under the ESPP Purchase on May 31, 2024.

Read SEC document
August 13, 2024 Filed Aug 15, 2024 20:09 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,337 $22.89 $53,493.93
Disclosure

SEC source: 0001714899-24-000176 · wk-form4_1723752552.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,268

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · balance_after: Includes 123,810 RSUs.

Read SEC document
July 01, 2024 Filed Jul 4, 2024 01:13 UTC SaleCommon Stock 100 $22.80 $2,280.00
Disclosure

SEC source: 0001714899-24-000156 · wk-form4_1720055619.xml · nonDerivative · entry 3

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,404

F2 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 1, 2023.

F1 · balance_after: Includes 18,467 unvested RSUs.

Read SEC document
July 01, 2024 Filed Jul 4, 2024 01:13 UTC SaleCommon Stock 29,900 $22.12 $661,388.00
Disclosure

SEC source: 0001714899-24-000156 · wk-form4_1720055619.xml · nonDerivative · entry 2

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,504

F2 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 1, 2023.

F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $21.80 to $22.78 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F1 · balance_after: Includes 18,467 unvested RSUs.

F4 · balance_after: Reflects an allocation of 11,784 shares from the Steven Edward Krognes Revocable Trust to the Reporting Person.

Read SEC document
July 01, 2024 Filed Jul 4, 2024 01:13 UTC
SATO VICKI LDirector
SaleCommon Stock 100 $22.86 $2,286.00
Disclosure

SEC source: 0001714899-24-000155 · wk-form4_1720055578.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,256

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.

F3 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
July 01, 2024 Filed Jul 4, 2024 01:13 UTC
SATO VICKI LDirector
SaleCommon Stock 2,980 $22.12 $65,917.60
Disclosure

SEC source: 0001714899-24-000155 · wk-form4_1720055578.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,356

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $21.86 to $22.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
June 13, 2024 Filed Jul 4, 2024 01:13 UTC SaleCommon Stock 688 $21.79 $14,991.52
Disclosure

SEC source: 0001714899-24-000156 · wk-form4_1720055619.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,620

F1 · balance_after: Includes 18,467 unvested RSUs.

Read SEC document
June 06, 2024 Filed Jun 11, 2024 00:06 UTC SaleCommon Stock 1,458 $21.73 $31,682.34
Disclosure

SEC source: 0001714899-24-000145 · wk-form4_1718064363.xml · nonDerivative · entry 1

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,038

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 7, 2024.

F2 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:33 UTC GrantStock Option (right to buy) · Derivative 17,901 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001714899-24-000142 · wk-form4_1717540391.xml · derivative · entry 3

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,901

Underlying: Common Stock · 17,901 shares

Expires 2034-05-31

F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:33 UTC GrantCommon Stock 5,967 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000142 · wk-form4_1717540391.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,308

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 18,467 unvested RSUs.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:32 UTC GrantStock Option (right to buy) · Derivative 17,901 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001714899-24-000141 · wk-form4_1717540348.xml · derivative · entry 2

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,901

Underlying: Common Stock · 17,901 shares

Expires 2034-05-31

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:32 UTC GrantCommon Stock 5,967 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000141 · wk-form4_1717540348.xml · nonDerivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,680

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 6595 unvested RSUs.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:31 UTC GrantStock Option (right to buy) · Derivative 17,901 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001714899-24-000140 · wk-form4_1717540308.xml · derivative · entry 5

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,901

Underlying: Common Stock · 17,901 shares

Expires 2034-05-31

F6 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:31 UTC GrantCommon Stock 5,967 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000140 · wk-form4_1717540308.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,880,539

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:30 UTC
SATO VICKI LDirector
GrantStock Option (right to buy) · Derivative 17,901 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001714899-24-000138 · wk-form4_1717540239.xml · derivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,901

Underlying: Common Stock · 17,901 shares

Expires 2034-05-31

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:30 UTC
SATO VICKI LDirector
GrantCommon Stock 5,967 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000138 · wk-form4_1717540239.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,336

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:30 UTC GrantStock Option (right to buy) · Derivative 17,901 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001714899-24-000137 · wk-form4_1717540199.xml · derivative · entry 2

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,901

Underlying: Common Stock · 17,901 shares

Expires 2034-05-31

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:30 UTC GrantCommon Stock 5,967 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000137 · wk-form4_1717540199.xml · nonDerivative · entry 1

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,496

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:29 UTC GrantStock Option (right to buy) · Derivative 17,901 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001714899-24-000136 · wk-form4_1717540157.xml · derivative · entry 4

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,901

Underlying: Common Stock · 17,901 shares

Expires 2034-05-31

F5 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:29 UTC GrantCommon Stock 5,967 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000136 · wk-form4_1717540157.xml · nonDerivative · entry 1

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,496

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:28 UTC GrantStock Option (right to buy) · Derivative 17,901 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001714899-24-000135 · wk-form4_1717540113.xml · derivative · entry 3

FLATLEY JAY T · CIK 0001189130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,901

Underlying: Common Stock · 17,901 shares

Expires 2034-05-31

F5 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:28 UTC GrantCommon Stock 5,967 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000135 · wk-form4_1717540113.xml · nonDerivative · entry 1

FLATLEY JAY T · CIK 0001189130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,183

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,967 unvested RSUs.

F3 · balance_after: Includes shares previously reported as held by The Flatley Family Trust.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:27 UTC
Harris ErikDirector
GrantStock Option (right to buy) · Derivative 17,901 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001714899-24-000134 · wk-form4_1717540070.xml · derivative · entry 2

Harris Erik · CIK 0001780113 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,901

Underlying: Common Stock · 17,901 shares

Expires 2034-05-31

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:27 UTC
Harris ErikDirector
GrantCommon Stock 5,967 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000134 · wk-form4_1717540070.xml · nonDerivative · entry 1

Harris Erik · CIK 0001780113 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,052

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 9,402 unvested RSUs.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:20 UTC GrantStock Option (right to buy) · Derivative 17,901 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001714899-24-000133 · wk-form4_1717539614.xml · derivative · entry 2

Klein Peter S · CIK 0001478007 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,901

Underlying: Common Stock · 17,901 shares

Expires 2034-05-31

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:20 UTC GrantCommon Stock 5,967 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000133 · wk-form4_1717539614.xml · nonDerivative · entry 1

Klein Peter S · CIK 0001478007 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,496

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
May 15, 2024 Filed May 17, 2024 20:28 UTC
SATO VICKI LDirector
SaleCommon Stock 1,674 $20.39 $34,132.86
Disclosure

SEC source: 0001714899-24-000122 · wk-form4_1715977693.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,369

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted September 27, 2023.

F2 · balance_after: Includes 4,216 unvested RSUs.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 21:14 UTC
SATO VICKI LDirector
SaleCommon Stock 1,666 $18.29 $30,471.14
Disclosure

SEC source: 0001714899-24-000104 · wk-form4_1713388471.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,043

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted September 27, 2023.

F2 · balance_after: Includes 4,216 unvested RSUs.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 22:07 UTC SaleCommon Stock 92,500 $20.50 $1,896,250.00
Disclosure

SEC source: 0001714899-24-000098 · wk-form4_1712095651.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,341

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 1, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $20.06 to $20.73 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 16,716 unvested RSUs.

Read SEC document
March 29, 2024 Filed Mar 29, 2024 21:59 UTC
Watts Ryan J.Director · President and CEO
GiftCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001714899-24-000097 · wk-form4_1711749539.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,202,604

F1 · shares: Reflects an in-kind charitable contribution of 40,000 shares of DNLI to a donor advised fund.

F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:27 UTC
SATO VICKI LDirector
SaleCommon Stock 1,666 $20.10 $33,486.60
Disclosure

SEC source: 0001714899-24-000092 · wk-form4_1710880039.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,709

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.72 to $20.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 4,216 unvested RSUs.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:38 UTC
SATO VICKI LDirector
SaleCommon Stock 1,666 $18.37 $30,604.42
Disclosure

SEC source: 0001714899-24-000066 · wk-form4_1708468690.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,375

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $18.24 to $18.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 4,216 RSUs.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 02:14 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 20,128 $17.66 $355,460.48
Disclosure

SEC source: 0001714899-24-000059 · wk-form4_1708049627.xml · nonDerivative · entry 2

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,341

F4 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.

F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 129,435 RSUs.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 02:14 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 1,405 $17.79 $24,994.95
Disclosure

SEC source: 0001714899-24-000060 · wk-form4_1708049673.xml · nonDerivative · entry 2

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 143,605

F4 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29,2023.

F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.55 to $17.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price

F3 · balance_after: Includes 129,435 RSUs.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 02:15 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 9,589 $17.29 $165,793.81
Disclosure

SEC source: 0001714899-24-000061 · wk-form4_1708049710.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,067

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price

F3 · balance_after: Includes 202,200 RSUs.

F4 · balance_after: Reflects 25,759 shares previously disclosed as held indirectly; but have been determined to be held directly.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 02:14 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,716 $17.29 $46,959.64
Disclosure

SEC source: 0001714899-24-000059 · wk-form4_1708049627.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 207,469

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 129,435 RSUs.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 02:16 UTC SaleCommon Stock 2,750 $17.29 $47,547.50
Disclosure

SEC source: 0001714899-24-000062 · wk-form4_1708049752.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,841

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.07 to $17.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 16,716 RSUs.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 02:14 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,784 $17.29 $48,135.36
Disclosure

SEC source: 0001714899-24-000060 · wk-form4_1708049673.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,010

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 129,435 RSUs.

Read SEC document
February 08, 2024 Filed Feb 12, 2024 21:48 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001714899-24-000042 · wk-form4_1707774481.xml · derivative · entry 3

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,078

Underlying: Common Stock · 50,000 shares

Expires 2025-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.

Read SEC document
February 08, 2024 Filed Feb 12, 2024 21:48 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionCommon Stock 50,000 $0.68 $34,000.00
Disclosure

SEC source: 0001714899-24-000042 · wk-form4_1707774481.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,185

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 136,721 RSUs.

F2 · balance_after: Reflects 15,558 shares previously disclosed as held indirectly; but have been determined to be held directly.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.